吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Oct 19 2017

Full Issue

Rumor Mill Churning About Who Next Drug Czar Will Be After Original Pick Bows Out

Rep. Tom Marino (R-Pa.) withdrew his name from consideration after reports tying him to legislation that undermined the Drug Enforcement Administration's power during the opioid crisis.

The Trump administration has gone nine months without a permanent drug czar. But within hours of the announcement that Rep. Tom Marino (R-Pa.) had withdrawn his name from consideration on Tuesday, the D.C. rumor mill was up and running. Potential candidates, according to administration officials, Capitol Hill staffers, and others in the world of drug and addiction treatment policy, include a who鈥檚-who of players in the current battle against the opioid crisis. (Facher, 10/18)

President Donald Trump鈥檚 former nominee to be the nation鈥檚 drug czar is defending his role in writing a law that critics say weakened the government鈥檚 authority to stop companies from distributing opioids. Rep. Tom Marino, R-Pa., said he鈥檚 proud of his work on the 2016 law, which passed without opposition in the House and Senate and was signed by President Barack Obama. (10/18)

In other news on the opioid epidemic聽鈥

The state of California wants to revoke the wholesale license for a facility run by Cardinal Health, one of the nation鈥檚 largest pharmaceutical distributors, for failing to note a series of unusual sales of an opioid painkiller and three other tightly regulated medicines to a pharmacy. Between 2013 and 2015, the Cardinal Health outpost in Valencia, Calif., sold increasingly large quantities of the controlled substances 鈥 including Norco, which is a mixture of acetaminophen and hydrocodone 鈥 to the pharmacy, which state officials called 鈥渞ed flags.鈥 Another medicine was the Xanax anxiety pill. (Silverman, 10/18)

Aonce-a-month shot to treat opioid addiction was as effective in maintaining short-term abstinence from heroin and similar drugs as a more commonly prescribed daily treatment, according to a Norwegian study released Wednesday. The study is believed to be the first to directly compare Vivitrol聽鈥 administered as a monthly shot 鈥 with a combination drug treatment sold under the brand name Suboxone. In the U.S. and many other countries, Suboxone or methadone have been the standard medical treatment for people with an opioid use disorder. (Armstrong, 10/18)

Federal, county and city court officials are looking hard at Buffalo, N.Y.鈥檚 new opioid crisis intervention court as one potential model solution to the epidemic of heroin and opioid overdoses that continue to devastate families and communities across America, taxing local governments, first responders and the nation鈥檚 criminal justice system. (Westervelt, 10/18)

Rep. John Delaney, D-Potomac, announced Tuesday that he is co-sponsoring legislation to make it easier for the Drug Enforcement Administration to combat the opioid epidemic. The bill, called the 鈥淥pioid Immediate Suspension Order Act of 2017,鈥 was introduced Monday by Rep. Gerry Connolly, D-Virginia. Four Democratic representatives, including Delaney, have co-sponsored the legislation, but no Republicans, according to Connolly鈥檚 office. (Jacob, 10/18)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, August 4
  • Monday, August 3
  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
  • Tuesday, July 28
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF